AlphaYouTM
Congress trade
Rep. Thomas MacArthur (R-NJ) bought $100K-$250K of Johnson & Johnson (JNJ) stock
Thomas MacArthur, U.S. Representative (R-NJ), disclosed a purchase of Johnson & Johnson (JNJ) stock worth $100K-$250K in a STOCK Act filing on Jul 9, 2017.
The trade happened on Jun 13, 2017, 26 days before it was made public.
JNJ has moved +93.9% since the trade date, from $132.02 to $256.03 (Oct 2, 2026 close).
- Traded
- Jun 13, 2017
- Disclosed
- Jul 9, 2017
- Filing delay
- 26 days
- Price since
- +93.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (27)
- SellJCI$50K-$100KJul 9, 2017
- SellMLPX$50K-$100KJul 9, 2017
- BuyNEP$50K-$100KJul 9, 2017
- SellAHONY$15K-$50KJul 9, 2017
- SellDCP$15K-$50KJul 9, 2017
- BuyDM$15K-$50KJul 9, 2017
- SellEADSY$15K-$50KJul 9, 2017
- BuyWGP$15K-$50KJul 9, 2017
- SellEONGY$1K-$15KJul 9, 2017
- BuyHD$1K-$15KJul 9, 2017
- BuyIEMG$1K-$15KJul 9, 2017
- BuyINTC$1K-$15KJul 9, 2017
- SellJCI$1K-$15KJul 9, 2017
- SellJCI$1K-$15KJul 9, 2017
- BuyJNJ$1K-$15KJul 9, 2017
- BuyJNJ$1K-$15KJul 9, 2017
- BuyJWN$1K-$15KJul 9, 2017
- BuyMCD$1K-$15KJul 9, 2017
- BuyMSFT$1K-$15KJul 9, 2017
- BuyNEE$1K-$15KJul 9, 2017
More JNJ insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.